New aromatase inhibitors. Synthesis and inhibitory activity of pyridinyl-substituted flavanone derivatives. 2002

Christelle Pouget, and Catherine Fagnere, and Jean-Philippe Basly, and Gerard Habrioux, and Albert-José Chulia
UPRES EA 1085, Biomolécules et cibles cellulaires tumorales, Faculté de Pharmacie, 2 rue du Docteur Marcland, 87025 Limoges cedex, France.

Two (E)-pyridinyl-substituted flavanone derivatives were synthesized and UV irradiation of these compounds afforded a Z-enriched mixture. These products were tested for their ability to inhibit the cytochrome P450 aromatase. It was observed that the introduction of a pyridinylmethylene group at carbon 3 on flavanone nucleus led to a significant increase of aromatase inhibitory effect. Moreover, configuration had a substantial influence on the aromatase inhibitory activity since (E)-isomers were found to be more active than (Z)-isomers.

UI MeSH Term Description Entries
D008297 Male Males
D008861 Microsomes Artifactual vesicles formed from the endoplasmic reticulum when cells are disrupted. They are isolated by differential centrifugation and are composed of three structural features: rough vesicles, smooth vesicles, and ribosomes. Numerous enzyme activities are associated with the microsomal fraction. (Glick, Glossary of Biochemistry and Molecular Biology, 1990; from Rieger et al., Glossary of Genetics: Classical and Molecular, 5th ed) Microsome
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D010920 Placenta A highly vascularized mammalian fetal-maternal organ and major site of transport of oxygen, nutrients, and fetal waste products. It includes a fetal portion (CHORIONIC VILLI) derived from TROPHOBLASTS and a maternal portion (DECIDUA) derived from the uterine ENDOMETRIUM. The placenta produces an array of steroid, protein and peptide hormones (PLACENTAL HORMONES). Placentoma, Normal,Placentome,Placentas,Placentomes
D011725 Pyridines Compounds with a six membered aromatic ring containing NITROGEN. The saturated version is PIPERIDINES.
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D005419 Flavonoids A group of phenyl benzopyrans named for having structures like FLAVONES. 2-Phenyl-Benzopyran,2-Phenyl-Chromene,Bioflavonoid,Bioflavonoids,Flavonoid,2-Phenyl-Benzopyrans,2-Phenyl-Chromenes,2 Phenyl Benzopyran,2 Phenyl Benzopyrans,2 Phenyl Chromene,2 Phenyl Chromenes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000735 Androstenedione A delta-4 C19 steroid that is produced not only in the TESTIS, but also in the OVARY and the ADRENAL CORTEX. Depending on the tissue type, androstenedione can serve as a precursor to TESTOSTERONE as well as ESTRONE and ESTRADIOL. 4-Androstene-3,17-dione,delta-4-Androstenedione,4 Androstene 3,17 dione,delta 4 Androstenedione
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships

Related Publications

Christelle Pouget, and Catherine Fagnere, and Jean-Philippe Basly, and Gerard Habrioux, and Albert-José Chulia
September 1991, Journal of medicinal chemistry,
Christelle Pouget, and Catherine Fagnere, and Jean-Philippe Basly, and Gerard Habrioux, and Albert-José Chulia
November 1991, Archiv der Pharmazie,
Christelle Pouget, and Catherine Fagnere, and Jean-Philippe Basly, and Gerard Habrioux, and Albert-José Chulia
May 2000, Bioorganic & medicinal chemistry,
Christelle Pouget, and Catherine Fagnere, and Jean-Philippe Basly, and Gerard Habrioux, and Albert-José Chulia
June 1985, Journal of medicinal chemistry,
Christelle Pouget, and Catherine Fagnere, and Jean-Philippe Basly, and Gerard Habrioux, and Albert-José Chulia
February 1997, Chemical & pharmaceutical bulletin,
Christelle Pouget, and Catherine Fagnere, and Jean-Philippe Basly, and Gerard Habrioux, and Albert-José Chulia
September 2010, Bioorganic & medicinal chemistry letters,
Christelle Pouget, and Catherine Fagnere, and Jean-Philippe Basly, and Gerard Habrioux, and Albert-José Chulia
October 1991, Archiv der Pharmazie,
Christelle Pouget, and Catherine Fagnere, and Jean-Philippe Basly, and Gerard Habrioux, and Albert-José Chulia
April 2012, Bioorganic & medicinal chemistry,
Christelle Pouget, and Catherine Fagnere, and Jean-Philippe Basly, and Gerard Habrioux, and Albert-José Chulia
February 2013, Medicinal chemistry (Shariqah (United Arab Emirates)),
Christelle Pouget, and Catherine Fagnere, and Jean-Philippe Basly, and Gerard Habrioux, and Albert-José Chulia
January 2008, Acta poloniae pharmaceutica,
Copied contents to your clipboard!